news

 

U.S law firm Weil, Gotshal & Manges and Wong & Partners, Baker McKenzie’s Malaysia member firm, have guided investment firm Global Infrastructure Partners (GIP) and a consortium led by Khazanah Nasional Bhd, respectively, on a $2.6 billion take-private offer for Malaysia Airports Holdings (MAH).

Majority shareholder Khazanah, along with the Employees Provident Fund (EPF), GIP, and Abu Dhabi Investment Authority (ADIA), are jointly offering to buy all of the remaining shares (58.78 percent) in MAH not already owned by them.

Upon completion of the deal, Khazanah will increase its ownership of MAHB to 40 percent from 33.2 percent, with the EPF raising it to 30 percent from 7.9 percent. ADIA and GIP will hold the remaining 30 percent stake.

The deal would be Malaysia’s largest acquisition in nearly three years, according to Dealogic.

The Weil team that represented GIP on the deal was led by partners Murray Cox and Brendan Moylan, supported by David McKendrick, Mark Spiller, Alex Long, and Melanie Yu.

The Wong & Partners team representing the consortium in Malaysia was led by partner Munir Abdul Aziz.

 

TO CONTACT EDITORIAL TEAM, PLEASE EMAIL ALBEDITOR@THOMSONREUTERS.COM

Related Articles

A&O Shearman advises Allianz on $1.6 bln Singapore insurance deal

by Nimitt Dixit |

A&O Shearman has advised German insurer Allianz on the acquisition of a 51 percent stake in Singapore's Income Insurance for S$2.2 billion ($1.6 billion), the latest major deal in Singapore’s buzzing insurance sector.

INDIA REPORT: Merger Momentum

by Nimitt Dixit |

Despite global uncertainties, India's M&A landscape remains robust, with domestic deals driving growth and diverse sectors attracting investments. Experts predict a positive outlook for H2 2024, bolstered by policy continuity and abundant dry powder.

Simpson Thacher, Nishimura act on Blackstone’s $2.17 bln Japan pharma sale

by Nimitt Dixit |

Japanese law firm Nishimura & Asahi has represented private equity group MBK Partners on its acquisition of drugmaker Alinamin Pharmaceuticals for 350 billion yen ($2.17 billion) from PE giant Blackstone, which was advised by its longstanding firm Simpson Thacher & Bartlett.